Market closedNon-fractional
Neogen/NEOG
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Neogen
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Ticker
NEOG
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Lansing, United States
Employees
2,640
Website
www.neogen.com
Neogen Metrics
BasicAdvanced
$3.3B
Market cap
2091.51
P/E ratio
$0.01
EPS
1.19
Beta
-
Dividend rate
Price and volume
Market cap
$3.3B
Beta
1.19
Financial strength
Current ratio
3.817
Quick ratio
2.167
Long term debt to equity
28.752
Total debt to equity
28.832
Interest coverage (TTM)
1.18%
Management effectiveness
Return on assets (TTM)
1.79%
Return on equity (TTM)
0.05%
Valuation
Price to earnings (TTM)
2,091.51
Price to revenue (TTM)
3.52
Price to book
1.04
Price to tangible book (TTM)
-6.17
Price to free cash flow (TTM)
-248.34
Growth
Revenue change (TTM)
28.93%
Earnings per share change (TTM)
-108.56%
3-year revenue growth
27.33%
3-year earnings per share growth
-76.67%
What the Analysts think about Neogen
Analyst Ratings
Majority rating from 2 analysts.
Neogen Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$229M
-0.35%
Net income
-$2M
-41.18%
Profit margin
-0.87%
-41.22%
Neogen Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$0.14
$0.11
$0.11
$0.12
-
Expected
-$0.04
$0.13
$0.14
$0.14
$0.11
Surprise
-500.00%
-12.00%
-21.43%
-14.29%
-
Neogen News
AllArticlesVideos
Neogen® Launches Petrifilm® Automated Feeder to Improve Efficiency of High-Throughput Food Safety Testing
PRNewsWire·1 week ago
Neogen® MDS Awarded Contract from USDA Food Safety and Inspection Service
PRNewsWire·3 weeks ago
Neogen® Releases CelluSmart Technology for Biofuel Industry
PRNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neogen stock?
Neogen (NEOG) has a market cap of $3.3B as of July 04, 2024.
What is the P/E ratio for Neogen stock?
The price to earnings (P/E) ratio for Neogen (NEOG) stock is 2091.51 as of July 04, 2024.
Does Neogen stock pay dividends?
No, Neogen (NEOG) stock does not pay dividends to its shareholders as of July 04, 2024.
When is the next Neogen dividend payment date?
Neogen (NEOG) stock does not pay dividends to its shareholders.
What is the beta indicator for Neogen?
Neogen (NEOG) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Neogen stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.